Authors:
REGIDOR PA
KIND EM
CALLIES R
METZ KA
REGIDOR M
EICKHOFF C
SCHINDLER AE
Citation: Pa. Regidor et al., DETECTION OF ENDOMETRIOSIS DURING CESAREA N-SECTION BECAUSE OF HELLP-SYNDROME IN THE 32ND WEEK OF GESTATION, Gynakologisch-geburtshilfliche Rundschau, 38(1), 1998, pp. 21-24
Citation: C. Oberhoff et al., ADJUVANT TAMOXIFEN TREATMENT IN BREAST-CANCER INDUCES NO ACTIVATION OF BLOOD-COAGULATION, European journal of cancer, 34, 1998, pp. 14-14
Citation: C. Oberhoff et al., BLOOD-COAGULATION AND FIBRINOLYSIS AFTER ORAL OR INTRAVENOUS CYCLOPHOSPHAMIDE CONTAINING ADJUVANT CMF-CHEMOTHERAPY, European journal of cancer, 34, 1998, pp. 15-15
Authors:
CARMICHAEL J
KEIZER HJ
CUPISSOL D
MILLIEZ J
SCHEIDEL P
SCHINDLER AE
Citation: J. Carmichael et al., USE OF GRANISETRON IN PATIENTS REFRACTORY TO PREVIOUS TREATMENT WITH ANTIEMETICS, Anti-cancer drugs, 9(5), 1998, pp. 381-385
Authors:
REGIDOR PA
CALLIES R
REGIDOR M
SCHINDLER AE
Citation: Pa. Regidor et al., EXPRESSION OF THE CELL-ADHESION MOLECULES ICAM-1 AND VCAM-1 IN THE CYTOSOL OF BREAST-CANCER TISSUE, BENIGN BREAST-TISSUE AND CORRESPONDING SERA, European journal of gynaecological oncology, 19(4), 1998, pp. 377-383
Citation: K. Kato et al., A COMPUTER-BASED, TEMPERATURE-CONTROLLED BIPOLAR ELECTROCOAGULATION SYSTEM - II - OPTIMAL TEMPERATURE AND COAGULATION TIME, European journal of obstetrics, gynecology, and reproductive biology, 78(1), 1998, pp. 103-107
Authors:
OBERHOFF C
SZYMECZEK J
HOFFMANN O
WINKLER UH
KAISER S
SCHINDLER AE
Citation: C. Oberhoff et al., ADJUVANT ANTIESTROGEN TREATMENT WITH TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - A LONGITUDINAL-STUDY OF BLOOD-COAGULATION AND FIBRINOLYSIS, Breast cancer research and treatment, 50(1), 1998, pp. 73-81
Authors:
REGIDOR PA
REGIDOR M
SCHINDLER AE
WINTERHAGER E
Citation: Pa. Regidor et al., ABERRANT EXPRESSION PATTERN OF GAP JUNCTION CONNEXINS IN ENDOMETRIOTIC TISSUES, Molecular human reproduction, 3(5), 1997, pp. 375-381
Authors:
HEINEMANN LAJ
WILLSHAHAB L
VANKESTEREN P
GOOREN LJG
QUAST A
PIETSCH H
KONRAD N
HELGE H
GRUTERS A
KNAPPE G
VENTZ M
PRANGE G
UBELHACK R
BANASCHAK K
CAVALLARI C
MACRELLI S
HINKEL GK
JUSTUS B
SAREMBE B
ABUSCHENKO E
MOESLER T
SCHINDLER AE
REGIDUR PA
MADJIDIAN K
BRAENDLE LW
KLEINKAUFHOUCKEN A
HORN HJ
MICHEL W
MORLOT M
VEISMANN S
ZIEGLER R
KREMPIEN R
ALENFELD F
HEINRICH U
SIPPELL WG
WILLE R
LASCHET R
ALEXANDER H
GLANDER HJ
SCHWARZE I
HOEPFFNER W
DIEDRICH K
SCHILL T
HEISE HR
LEHNERT H
SCHLICHTHAAR H
WEISE W
GERLOFF C
NICKEL I
BURMANNREUTER H
KRAUSE W
FLOHR J
PLEWIG G
WOLF H
SCHWARZ HP
BECKER A
SCHMIDT C
SIEGELALMASRY E
MIX M
OTTERMANN B
RANKE MB
GRAUER ML
TELLER W
HOMOKI J
WALDHAUSER F
KAISER E
BALJER E
EIDEN R
OTT F
Citation: Laj. Heinemann et al., SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 169-178
Authors:
KUHLMANN M
GARTNER A
SCHINDLER EM
REGIDOR PA
BUHLER K
SCHINDLER AE
Citation: M. Kuhlmann et al., UTERINE LEIOMYOMATA AND STERILITY - THERAPY WITH GONADOTROPIN-RELEASING-HORMONE AGONISTS AND LEIOMYOMECTOMY, Gynecological endocrinology, 11(3), 1997, pp. 169-174
Citation: Ae. Schindler, LONG-TERM RESULTS OF GNRH AGONIST THERAPY WITH RESPECT TO THE QUALITY-OF-LIFE, Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 224-225
Citation: Ae. Schindler, NEW ASPECTS OF TRANSDERMAL ESTROGEN REPLA CEMENT THERAPY - RESEARCH AND PRACTICE, Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 529-529
Authors:
REGIDOR PA
REGIDOR M
KATO K
BIER UW
BUHLER K
SCHINDLER AE
Citation: Pa. Regidor et al., LONG-TERM FOLLOW-UP ON THE TREATMENT OF ENDOMETRIOSIS WITH THE GNRH-AGONIST BUSERELINACETATE - LONG-TERM FOLLOW-UP DATA (UP TO 98 MONTHS) OF 42 PATIENTS WITH ENDOMETRIOSIS WHO WERE TREATED WITH GNRH-AGONIST BUSERELINACETATE (SUPRECUR(R)), WERE EVALUATED IN RESPECT OF RECURRENCE OF PAIN SYMPTOMS AND PREGNANCY OUTCOME, European journal of obstetrics, gynecology, and reproductive biology, 73(2), 1997, pp. 153-160
Authors:
WINKLER UH
HOLSCHER T
SCHULTE H
ZIERLEYN JP
COLLET W
SCHINDLER AE
Citation: Uh. Winkler et al., ETHINYLESTRADIOL-20 VERSUS 30-MU-G COMBINED WITH 150-MU-G DESOGESTREL- A LARGE COMPARATIVE-STUDY OF THE EFFECTS OF 2 LOW-DOSE ORAL-CONTRACEPTIVES ON THE HEMOSTATIC SYSTEM, Gynecological endocrinology, 10(4), 1996, pp. 265-271
Authors:
KATO K
BUHLER K
KLESSEN C
KOCH R
SCHINDLER AE
Citation: K. Kato et al., A COMPUTER-BASED, TEMPERATURE-CONTROLLED BIPOLAR ELECTROCOAGULATION SYSTEM, European journal of obstetrics, gynecology, and reproductive biology, 68(1-2), 1996, pp. 119-122
Citation: B. Christensen et Ae. Schindler, CHOCOLATE CYST - FREQUENTLY MISINTERPRETE D AS OVARIAN ENDOMETRIOSIS, Geburtshilfe und Frauenheilkunde, 56(9), 1996, pp. 482-484
Citation: Uh. Winkler et Ae. Schindler, PROPHYLAXIS AND TREATMENT OF THROMBOEMBOL ISM DURING PREGNANCY, Geburtshilfe und Frauenheilkunde, 56(6), 1996, pp. 301-312
Authors:
WINKLER UH
SCHINDLER AE
ENDRIKAT J
DUSTERBERG B
Citation: Uh. Winkler et al., A COMPARATIVE-STUDY OF THE EFFECTS OF THE HEMOSTATIC SYSTEM OF 2 MONOPHASIC GESTODENE ORAL-CONTRACEPTIVES CONTAINING 20 MU-G AND 30 MU-G ETHINYLESTRADIOL, Contraception, 53(2), 1996, pp. 75-84
Authors:
WINKLER UH
OBERHOFF C
BIER U
SCHINDLER AE
GILLAIN D
Citation: Uh. Winkler et al., HEMOSTATIC EFFECTS OF 2 ORAL-CONTRACEPTIVES CONTAINING LOW-DOSES OF ETHINYL ESTRADIOL AND EITHER GESTODENE OR NORGESTIMATE - AN OPEN, RANDOMIZED, PARALLEL-GROUP STUDY, International journal of fertility and menopausal studies, 40(5), 1995, pp. 260-268